E2F1 Modulates p38 MAPK Phosphorylation via Transcriptional Regulation of ASK1 and Wip1*

The E2F family of transcription factors regulates a diverse array of cellular functions, including cell proliferation, cell differentiation, and apoptosis. Recent studies indicate that E2F can also regulate transcription of upstream components of signal transduction pathways. We show here that E2F1 modulates the activity of the p38 MAPK pathway via E2F1-induced transient up-regulation of p38 MAPK phosphorylation. The mechanism by which E2F1 modulates p38 MAPK phosphorylation involves transcriptional induction of the kinase ASK1, a member of the MAPKKK family that phosphorylates p38 MKKs. Subsequent E2F-dependent down-regulation of the p38 signaling pathway is achieved through E2F-induced up-regulation of Wip1, a phosphatase that dephosphorylates and inactivates p38. Both ASK1 and Wip1 are essential mediators of the E2F-p38 connection: knock down of ASK1 inhibits E2F1-induced phosphorylation of p38, whereas knock down of Wip1 prolongs E2F1-induced p38 phosphorylation. Furthermore, Wip1 knock down enhances E2F1-induced apoptosis. Therefore, our data reveal a novel link between a central signaling pathway and the transcription factor E2F and identify Wip1 as a modulator of E2F1-induced apoptosis.

[1]  K. Sakaguchi,et al.  Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.

[2]  Brigitte M Pützer,et al.  Gene expression changes in response to E2F1 activation. , 2002, Nucleic acids research.

[3]  S. Chellappan,et al.  Direct Binding of Apoptosis Signal-regulating Kinase 1 to Retinoblastoma Protein , 2004, Journal of Biological Chemistry.

[4]  K. Helin,et al.  CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase , 1999, Molecular and Cellular Biology.

[5]  Akira Nakagawara,et al.  PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.

[6]  S. D'souza,et al.  E2F1 stability is regulated by a novel-PKC/p38β MAP kinase signaling pathway during keratinocyte differentiation , 2006, Oncogene.

[7]  Yihong Ma,et al.  Identification of novel E2F1-regulated genes by microarray. , 2002, Archives of biochemistry and biophysics.

[8]  Stephen N. Jones,et al.  E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis , 2002, Molecular and Cellular Biology.

[9]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Ginsberg,et al.  Transcriptional regulation of AKT activation by E2F. , 2004, Molecular cell.

[11]  R. Spang,et al.  Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis , 2001, Molecular and Cellular Biology.

[12]  C. Sherr Cancer Cell Cycles , 1996, Science.

[13]  D. Ginsberg,et al.  E2F and Signal Transduction Pathways , 2005, Cell cycle.

[14]  J. Saklatvala The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. , 2004, Current opinion in pharmacology.

[15]  F. Christians,et al.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. , 2001, Genes & development.

[16]  L. Donehower,et al.  Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway , 2004, Nature Genetics.

[17]  Y. Doki,et al.  Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. , 2003, Cancer research.

[18]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[19]  D. Engelberg Stress-activated protein kinases-tumor suppressors or tumor initiators? , 2004, Seminars in cancer biology.

[20]  M. Oren,et al.  Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F , 2005, Cell Death and Differentiation.

[21]  Jeffrey R. Marks,et al.  Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.

[22]  Jiahuai Han,et al.  The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.

[23]  F. Vikhanskaya,et al.  Characterization of the 5’flanking Region of the Human chk1 Gene: Identification of E2F1 Functional Sites , 2003, Cell cycle.

[24]  Yanbin Dong,et al.  Gene expression profiling of E2F-1-induced apoptosis. , 2005, Gene.

[25]  Rakesh Nagarajan,et al.  Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway , 2003, Oncogene.

[26]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[27]  J. Inazawa,et al.  Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Y. Kalma,et al.  E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis , 2002, Oncogene.

[29]  L. Donehower,et al.  The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. , 2004, Molecular cell.

[30]  N. Nath,et al.  Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases , 1999, The EMBO journal.

[31]  Masaaki Adachi,et al.  p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.

[32]  H. Ichijo,et al.  The ASK1-MAP kinase cascades in mammalian stress response. , 2004, Journal of biochemistry.

[33]  Karen H. Vousden,et al.  p14ARF links the tumour suppressors RB and p53 , 1998, Nature.

[34]  D. Ginsberg,et al.  ATM is a target for positive regulation by E2F-1 , 2003, Oncogene.

[35]  I. Yasinska,et al.  Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. , 2005, Archives of biochemistry and biophysics.

[36]  F. Skorpen,et al.  Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase. , 1998, Nucleic acids research.

[37]  J. DeGregori,et al.  The genetics of the E2F family of transcription factors: shared functions and unique roles. , 2002, Biochimica et biophysica acta.

[38]  L. Donehower,et al.  PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. , 2005, Genes & development.

[39]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[40]  D. Ginsberg,et al.  Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis* , 2004, Journal of Biological Chemistry.

[41]  K. Helin,et al.  Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.

[42]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[43]  H. A. Rogoff,et al.  Apoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2 , 2004, Molecular and Cellular Biology.

[44]  Joseph B. Rayman,et al.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. , 2000, Genes & development.

[45]  John T. Powers,et al.  E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. , 2004, Molecular cancer research : MCR.